PNC Financial Services Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,179
| Closed | -$193K | – | 4849 |
|
|
2023
Q4 | $193K | Buy |
8,179
+7,756
| +1,834% | +$183K | ﹤0.01% | 2170 |
|
|
2023
Q3 | $6.31K | Buy |
+423
| New | +$6.31K | ﹤0.01% | 3922 |
|
|
2022
Q2 | – | Sell |
-442
| Closed | -$2K | – | 4786 |
|
|
2022
Q1 | $2K | Hold |
442
| – | – | ﹤0.01% | 4249 |
|
|
2021
Q4 | $2K | Hold |
442
| – | – | ﹤0.01% | 4208 |
|
|
2021
Q3 | $2K | Hold |
442
| – | – | ﹤0.01% | 4155 |
|
|
2021
Q2 | $2K | Hold |
442
| – | – | ﹤0.01% | 4067 |
|
|
2021
Q1 | $2K | Hold |
442
| – | – | ﹤0.01% | 3984 |
|
|
2020
Q4 | $2K | Hold |
442
| – | – | ﹤0.01% | 3868 |
|
|
2020
Q3 | $4K | Hold |
442
| – | – | ﹤0.01% | 3733 |
|
|
2020
Q2 | $2K | Hold |
442
| – | – | ﹤0.01% | 3802 |
|
|
2020
Q1 | $0 | Sell |
442
-122
| -22% | – | ﹤0.01% | 4092 |
|
|
2019
Q4 | $2K | Buy |
564
+528
| +1,467% | +$1.87K | ﹤0.01% | 3817 |
|
|
2019
Q3 | $0 | Buy |
+36
| New | – | ﹤0.01% | 4137 |
|
|
2019
Q2 | – | Sell |
-10,260
| Closed | -$136K | – | 4165 |
|
|
2019
Q1 | $136K | Sell |
10,260
-2,860
| -22% | -$37.9K | ﹤0.01% | 2381 |
|
|
2018
Q4 | $104K | Buy |
13,120
+2,460
| +23% | +$19.5K | ﹤0.01% | 2435 |
|
|
2018
Q3 | $118K | Sell |
10,660
-700
| -6% | -$7.75K | ﹤0.01% | 2495 |
|
|
2018
Q2 | $152K | Buy |
+11,360
| New | +$152K | ﹤0.01% | 2367 |
|